We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Fresh Red Blood Cells No Better Than Older Ones

By HospiMedica International staff writers
Posted on 24 Dec 2019
The use of fresh red blood cells (RBCs), rather than standard-issue RBCs, does not demonstrate a benefit in the treatment of critically ill pediatric patients, according to a new study.

Researchers at Université Laval (Quebec City, Canada), Washington University (WUSTL; St. More...
Louis, MO, USA), the London School of Economics (United Kingdom), and other institutions conducted an international, randomized clinical trial to determine if transfusion of fresh RBCs reduced new or progressive multiple organ dysfunction syndrome (MODS), compared to standard-issue RBCs. In all, 1,461 patients (median age 1.8 years; 47.3% girls) were randomized on a 1:1 basis to fresh or standard-issue RBC groups. The main outcome was MODS, measured for 28 days or to discharge or death.

The results revealed no significant differences in new or progressive MODS in children between the fresh RBC (20.2%) and standard-issue RBC (18.2%) groups. The prevalence of sepsis was 25.8% in the fresh group and 25.3% in the standard-issue group; the prevalence of acute respiratory distress syndrome was 6.6% in the fresh group and 4.8% in the standard-issue group; and intensive care unit (ICU) mortality was 4.5% in the fresh RBC group, compared to 3.5 % in the standard-issue RBC group. The study was published on December 10, 2019, in JAMA.

“Our findings indicate that doctors should not be afraid to use older red cells in critically ill children. Those who are showing a preference for fresh red cells might consider discontinuing this practice unless there are extenuating circumstances,” said co-lead author Philip Spinella, MD, of the WUSTL pediatric critical care translational research program. “The findings also provide good news for blood banks, which will likely feel less pressure to respond to requests for fresh red cells.”

RBC transfusions are commonly given to critically ill children for conditions such as trauma, cancer chemotherapy, intraoperative bleeding, as well as for chronic conditions, such as thalassemia and sickle cell disease. Transfusing the oldest RBCs in the stored inventory first is standard practice among many hospitals. However, some hospitals preferentially give fresh RBCs to critically ill children, even though clinical studies supporting the benefits of this practice have been lacking.

Related Links:
Université Laval
Washington University
London School of Economics



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.